CClinicalTrials.gg
Active, not recruitingNCT05988931Updated Aug 28, 2026

Technology Interventions for Youth Alcohol Use

An interventional study of Web Program + App and Web Program + App + Text Messages in Alcohol Drinking, sponsored by University of Michigan. Active, not recruiting at 1 site in United States. Open to participants aged 12 Years to 19 Years. Per ClinicalTrials.gov, last updated 2026-08-28.

Sponsored by University of Michigan · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
1,406
Allocation
Randomized
Ages
12 Years to 19 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the effects of two programs to prevent/reduce alcohol misuse among youth primary care patients. Depending on their study condition, youth will receive a brief web-based computer program or the web program + 8 weeks of supportive text messages. Parents/caregivers of youth are encouraged to use a freely available app to guide conversations with their child about drinking. This study will have significant impact by evaluating response to these scalable interventions which can be deployed widely in clinical care settings.

02

Conditions studied

  • Alcohol Drinking

Browse trials for

03

In context

Alcohol Drinking

925 studies on the registry are indexed under Alcohol Drinking; 172 are open to participants now.

This study's enrollment of 1,406 is above the median of 108 across 802 interventional studies indexed under Alcohol Drinking.

Browse Alcohol Drinking studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • patients age 12-19 within the Michigan Medicine health system who had a visit within the past 2 years; and
  • past 12-month alcohol use; and
  • patient has a phone that can receive text messages

Exclusion criteria

Exclusion Criteria:

  • patients who do not understand English; or
  • patients deemed unable to provide informed consent due to conditions that preclude understanding of assessment or intervention content; or
  • parent/guardian consent is not obtained; or
  • another child in household already enrolled in the study; or
  • ongoing participation in another behavioral health research study
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,406 participants (actual)

Study arms

  • Active comparator
    Web Program + App

    Brief intervention web program (rooted in Motivational Interviewing) recommended at enrollment with parent/caregiver recommended to download and use app (with strategies to talk to youth about drinking prevention).

    Behavioral: Web Program + App

  • Active comparator
    Web Program + App + Text Messages

    Brief intervention web program (rooted in Motivational Interviewing) recommended at enrollment with parent/caregiver recommended to download and use app (with strategies to talk to youth about drinking prevention) plus youth receive 8 weeks of text messages.

    Behavioral: Web Program + App + Text Messages

Interventions

  • BehavioralWeb Program + App

    Youth receive a brief interactive web program made available online to prevent alcohol misuse. The parent/caregiver app addresses monitoring and skill building for parents to communicate with the child about preventing underage drinking and drug use.

  • BehavioralWeb Program + App + Text Messages

    Youth receive a brief interactive web program made available online to prevent alcohol misuse. This is followed by 8 weeks of supportive text messages. The parent/caregiver app addresses monitoring and skill building for parents to communicate with the child about preventing underage drinking and drug use.

06

What researchers measure

Primary outcomes

  1. Change in Alcohol Consumption

    Alcohol consumption will be measured using total score on the 3-item Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) which includes typical quantity and frequency, and frequency of binge drinking (# of drinks modified by age based on the NIAAA Youth Guide). Higher score indicates worse outcomes.

    Time frame: 3-, 6-, 9- and 12- months post baseline

Secondary outcomes

  1. Change in Alcohol Related Consequences

    Alcohol related consequences will be measured using total score on the brief 18-item version of the Rutgers Alcohol Problem Index (RAPI). Higher score indicates worse outcomes.

    Time frame: 3-, 6-, 9- and 12- months post baseline

  2. Change in Other Drug Use

    Other drug use will be measured using scores derived from National Survey on Drug Use and Health (NSDUH) survey items for illicit (e.g., cannabis, cocaine, heroin) and prescription (i.e., in any way a doctor did not direct you to use; stimulants, sedatives, and opioids) drugs misuse. Higher scores indicate worse outcomes.

    Time frame: 3-, 6-, 9- and 12- months post baseline

  3. Change in Other Drug Use Consequences

    Other drug use consequences will be measured using total score on an 18-item version of the drug-focused RAPI. Higher score indicates worse outcomes.

    Time frame: 3-, 6-, 9- and 12- months post baseline

  4. Change in Depression Symptoms

    Depressive symptoms will be measured using the Patient Health Questionnaire-2 (PHQ-2). Higher scores indicate worse outcomes, with a score of ≥ 3 indicating a positive depression screen.

    Time frame: 3-, 6-, 9- and 12-month post baseline

07

Study locations

1 site
  • University of Michigan
    Ann Arbor, Michigan 48109, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05988931
Lead sponsor
University of Michigan
Collaborators
Patient-Centered Outcomes Research Institute
Responsible party
Maureen A Walton (Professor of Psychiatry, University of Michigan) — Principal investigator
First posted
Aug 14, 2023
Start date
Oct 25, 2023
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Aug 28, 2026

Study contacts

Maureen Walton, MPH, PhD
principal investigator · University of Michigan
Erin Bonar, PhD
principal investigator · University of Michigan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion